Results 101 to 110 of about 13,067 (212)

Chronic phase of Chagas disease: why should it be treated? A comprehensive review

open access: yesMemorias do Instituto Oswaldo Cruz, 2011
The pathogenesis and evolutive pattern of Chagas disease suggests that the chronic phase should be more widely treated in order to (i) eliminate Trypanosoma cruzi and prevent new inflammatory foci and the extension of tissue lesions, (ii) promote tissue ...
José Rodrigues Coura   +1 more
doaj   +1 more source

Regulatory lymphoid and myeloid cells determine the cardiac immunopathogenesis of Trypanosoma cruzi infection [PDF]

open access: yes, 2018
Chagas disease is a multisystemic disorder caused by the protozoan parasite Trypanosoma cruzi, which affects ~8 million people in Latin America, killing 7,000 people annually.
Abrahamsohn   +94 more
core   +3 more sources

Proteomic inventory of myocardial proteins from patients with chronic Chagas' cardiomyopathy [PDF]

open access: gold, 2006
Priscila Camillo Teixeira   +7 more
openalex   +2 more sources

Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of Trypanosoma cruzi –Seropositive Individuals [PDF]

open access: bronze, 2021
Maria Carmo P. Nunes   +19 more
openalex   +1 more source

A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses [PDF]

open access: yes, 2017
The extreme genetic diversity of the protozoan Trypanosoma cruzi has been proposed to be associated with the clinical outcomes of the disease it provokes: Chagas disease (CD).
Chillón-Marinas, Carlos   +6 more
core   +3 more sources

Integrated control of chagas disease for its elimination as public health problem: A review [PDF]

open access: yes, 2015
Chagas disease or American trypanosomiasis is, together with geohelminths, the neglected disease that causes more loss of years of healthy life due to disability in Latin America.
Segura, Elsa Leonor   +1 more
core   +4 more sources

Importance of Developing New Tools to Assess Cardiac Amyloidosis Using Echocardiography

open access: yes
Echocardiography, Volume 42, Issue 8, August 2025.
Claudio Tinoco Mesquita   +2 more
wiley   +1 more source

Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy

open access: yesScientific Reports, 2017
Chagas disease cardiomyopathy is a parasite-driven inflammatory disease to which there are no effective treatments. Here we evaluated the therapeutic potential of N,N-dimethylsphingosine(DMS), which blocks the production of sphingosine-1-phosphate(S1P ...
Juliana Fraga Vasconcelos   +10 more
doaj   +1 more source

Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy

open access: gold, 2021
Subhadip Choudhuri   +7 more
openalex   +1 more source

Molecular dissection of Chagas induced cardiomyopathy reveals central disease associated and druggable signaling pathways

open access: gold, 2020
Jacob M. Wozniak   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy